Press "Enter" to skip to content

CDC Issues Health Advisory on J&J Shot; Pfizer Ramps Up; STDs at All-Time High

Note that some links may require registration or subscription.

CDC issued a Health Advisory Alert about the single-dose Johnson & Johnson COVID-19 vaccine that was paused due to six cases of cerebral venous sinus thrombosis with thrombocytopenia.

Here’s why Biden administration health officials made the decision to pause. (Washington Post)

The pause has led to canceled appointments across states and means vaccinations at nursing homes and assisted living communities essentially have stopped. (New York Times, McKnight’s Long-Term Care News)

As of Wednesday at 8:00 a.m. EST, the unofficial U.S. COVID-19 toll stood at 31,346,923 cases and 563,449 deaths — up 77,971 and 841, respectively, in the previous 24 hours.

Pfizer ramped up production of its vaccine and said it can deliver 10% more doses to the U.S. by the end of May than previously agreed. (The Hill)

Regeneron is pursuing EUA expansion for its single-shot COVID-19 monoclonal antibody cocktail as preventive treatment after it helped cut the risk of symptomatic infections in households where someone else is ill by 81%. (CNN)

Moderna’s vaccine booster that targets the B.1.351 mutation first identified in South Africa, “closed the neutralizing titer gap for the variants of concern” in mice, the company said Tuesday.

The U.K. Com-Cov study that tests different COVID-19 vaccines in two-dose inoculations will expand to include shots made by Moderna and Novavax. (Reuters)

A phase II trial of IC14, an anti-CD14 monoclonal antibody to treat COVID-19 respiratory disease, is underway, NIH said.

The NFL will bar unvaccinated coaches and staff from working with players. (New York Times)

Here’s how a consulting hematologist at University College London Hospital linked cases of rare blood-clotting to the AstraZeneca COVID vaccine. (The Guardian)

Denmark announced it will completely stop administering the AstraZeneca COVID-19 vaccine, the first country to do so. (Reuters)

In other news:

  • Judy George covers neurology and neuroscience news for MedPage Today, writing about brain aging, Alzheimer’s, dementia, MS, rare diseases, epilepsy, autism, headache, stroke, Parkinson’s, ALS, concussion, CTE, sleep, pain, and more. Follow

Source: MedicalNewsToday.com